Clinical trials: Smoking Cessation
Smoking Cessation
Novel Smoking Cessation Drug for Schizophrenia
The investigators will evaluate effects of a novel drug that improves nicotinergic receptor function vs. placebo on short-term smoking abstinence in smokers with schizophrenia who have a high interest in quitting.
- Trial name
- TRENDS (NCT02230384)
- Testing
- Active JNJ Drug
- Where
- United States
- Volunteers
- 62 people
- Sponsor
- K.N. Roy Chengappa
Alcohol Drinking
Do Treatments for Smoking Cessation Affect Alcohol Drinking?
The purpose of this study is to examine the effect of smoking cessation medications on alcohol drinking. Effect of 2mg/day, 1mg/day, placebo varenicline was evaluated.
- Trial name
- NCT00580645
- Testing
- varenicline
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Yale University
Smoking Cessation, Insurance Coverage
Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit
This study is based on the hypothesis that access to smoking cessation treatment (SCT) reimbursement may significantly increase the number of successful quitters in a population of smokers motivated to quit by: 1) increasing the…
- Trial name
- ACCESSATION (NCT00818207)
- Testing
- Full Smoking Cessation Treatment Coverage (100%), No Smoking Cessation Treatment Coverage (0%)
- Where
- 56 sites in Canada
- Volunteers
- 1,380 people, healthy volunteers welcome
- Sponsor
- Pfizer
Smoking Cessation
Gradual vs. Abrupt Cessation Treatment for Smoking
This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping…
- Trial name
- NCT00297492
- Testing
- Reduction Phone Counseling, Abrupt Phone Counseling, Minimal Abrupt Phone Counseling
- Where
- United States
- Volunteers
- 750 people, healthy volunteers welcome
- Sponsor
- University of Vermont
TOBACCO USE CESSATION
Comparison of Standard Versus Extended Nicotine Patch Therapy for Smoking Cessation
This randomized double-blind, placebo-controlled will determine the relative efficacy of standard versus extended transdermal nicotine (TN) therapy for smoking cessation.
- Trial name
- NCT00364156
- Testing
- Standard Patch Treatment, 24-weeks of nicotine patch
- Where
- 2 sites in United States
- Volunteers
- 568 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Nicotine Dependence
Maintaining Nonsmoking
The research is based on a chronic disorder model of cigarette smoking which suggests that long-term treatment targeted to prevent relapse may be useful.
- Trial name
- NCT01162239
- Testing
- Varenicline, Initial Individual counseling, Check-ins with medical staff
- Where
- United States
- Volunteers
- 216 people, healthy volunteers welcome
- Sponsor
- University of California, San Francisco
Smoking Cessation
A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers
The primary objectives of this study are: To evaluate the pharmacokinetic (PK) parameters during repeat dosing of 1.5 mg or 3.0 mg cytisine when administered as the commercial 25-day schedule.
- Trial name
- NCT03303911
- Testing
- Cytisine
- Where
- United Kingdom
- Volunteers
- 26 people
- Sponsor
- Achieve Life Sciences
Cigarette Smoking, Nicotine Dependence
Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants
The purpose of this study is to ascertain: 1) the rate of smoking cessation obtained using an adaptive treatment algorithm developed in previous clinical trials, in order to calculate cost-effectiveness of the treatment; 2) the…
- Trial name
- LiveForLife2 (NCT01560507)
- Testing
- varenicline (Chantix), bupropion (Zyban), nicotine patches
- Where
- 2 sites in United States
- Volunteers
- 19 people
- Sponsor
- Duke University
Smoking Cessation
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
The purpose of this research study is to evaluate whether the investigational drug ganaxolone can help smokers quit smoking. Ganaxolone is a drug that has been investigated (in other research studies) for the treatment of…
- Trial name
- Ganaxolone (NCT01857531)
- Testing
- Ganaxolone, Nicotine Patch
- Where
- 4 sites in United States
- Volunteers
- 36 people
- Sponsor
- Jed E. Rose
Nicotine Dependence
Assessment of a Teachable Moment for Smoking Cessation
A teachable moment (TM) refers to life events or transitions, such as physician visits, early detection screening feedback, pregnancy, and hospitalization for, and diagnosis of, disease, that inspire health behavior change.
- Trial name
- TM (NCT00596440)
- Testing
- Transdermal nicotine patch
- Where
- United States
- Volunteers
- 234 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Nicotine Dependence
Varenicline for Adolescent Smoking Cessation
This is a placebo-controlled smoking cessation treatment study for adolescents ages 14-21. After assessment and inclusion into the study, participants will be randomized to receive a 12-week double blind course of varenicline or…
- Trial name
- NCT01509547
- Testing
- Varenicline
- Where
- United States
- Volunteers
- 157 people
- Sponsor
- Medical University of South Carolina
Tobacco Use Behavior
Smoking Prevention Through Social Connections Among Adolescents - ASPIRE
The central hypothesis of this study is that the addition of social influence strategies to a web-based program called ASPIRE will boost its success in lowering intention to use tobacco among adolescents and experiencing stronger…
- Trial name
- NCT02703597
- Testing
- Surveys, ASPIRE, GSA-ASPIRE-Network
- Where
- United States
- Volunteers
- 393 people, healthy volunteers welcome
- Sponsor
- University of Florida
Smoking Cessation, HIV
A Smoking Cessation Trial in HIV-infected Patients in South Africa
The purpose of this study is to conduct a randomized controlled trial (RCT) of intensive anti-smoking counseling plus nicotine replacement therapy versus intensive anti-smoking counseling alone among HIV-infected patients in…
- Trial name
- JHU (NCT01484340)
- Testing
- Nicotine, Intensive Counseling
- Where
- 3 sites in South Africa
- Volunteers
- 560 people
- Sponsor
- Johns Hopkins University
Cigarette Smoking, Schizophrenia
Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia
The purpose of this proposed pilot study is to examine the use of varenicline in people with schizophrenia to specifically assess tolerability and efficacy for smoking cessation.
- Trial name
- NCT00554840
- Testing
- varenicline
- Volunteers
- 16 people
- Sponsor
- University of Maryland, Baltimore
Smoking Cessation
Quit & Fit 2.0: Feasibility and Usability Testing
Pilot randomized controlled trial to compare tobacco cessation rates of two arms: a 6-week culturally tailored tobacco cessation intervention versus a 6-week personalized culturally-tailored tobacco cessation intervention among…
- Trial name
- NCT05878990
- Testing
- Culturally-tailored Tobacco Treatment, Culturally-tailored Content Newsletters, Control Preference Scale
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- Hackensack Meridian Health
Chronic Disease, Neoplasm
Family-supported Smoking Cessation for Chronically Ill Veterans
The overarching aim of the study is to evaluate in a randomized trial the impact of a family-supported intervention compared to a standard veteran-focused telephone counseling control group to promote smoking cessation among…
- Conditions
- Chronic Disease, Neoplasm, Cardiovascular Disease, Pulmonary Disease, Chronic Obstructive
- Trial name
- NCT00448344
- Testing
- Family-supported, Standard Telephone counseling
- Where
- United States
- Volunteers
- 471 people
- Sponsor
- US Department of Veterans Affairs
Smoking Cessation
Smoking Cessation Study In Healthy Adolescent Smokers
The study is designed to see if varenicline combined with age appropriate (adolescent) smoking cessation counseling will help teens quit smoking.
- Trial name
- NCT01312909
- Testing
- Varenicline 1mg BID, Varenicline 0.5mg BID
- Where
- 80 sites in United States, Canada and 4 more
- Volunteers
- 312 people
- Sponsor
- Pfizer
Tobacco Use Disorder
Effect of Galantamine on Short-term Abstinence
This is a randomized, double-blind, placebo-controlled study to test whether a medication called galantamine (Brand Name: Razadyne) will help smokers quit and whether it reduces cognitive problems that smokers experience during a…
- Trial name
- GAL-K (NCT01669538)
- Testing
- Galantamine
- Where
- United States
- Volunteers
- 98 people
- Sponsor
- University of Pennsylvania
Tobacco Dependence, Smoking
Bupropion SR Plus Counseling for Smoking Cessation
The purpose of this study was to determine if bupropion plus counseling was more effective than bupropion alone or counseling alone in helping smokers quit smoking.
- Trial name
- NCT01621009
- Testing
- Active bupropion + counseling, Active bupropion, No counseling
- Where
- United States
- Volunteers
- 463 people, healthy volunteers welcome
- Sponsor
- University of Wisconsin, Madison
Smokers
Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance…
- Trial name
- NCT00781599
- Testing
- Chantix, Adherence Counseling, Standard Counseling
- Where
- United States
- Volunteers
- 72 people
- Sponsor
- Nikki Nollen, PhD, MA